FilingSEC EDGAR8-K
Akari Therapeutics Amends CEO Compensation and Adds Equity-Based Awards
· SEC accepted
StageAgreement Signed
Filing content
The company amended its CEO's employment agreement to increase base salary and grant equity-based awards, subject to shareholder approval.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…